SIRT2-IN-16
SIRT2-IN-16 (compund 17) is a prostate-specific membrane antigen (PSMA) -targeted SIRT2 inhibitor[1].
Product Specifications
UNSPSC
12352211
Target
Sirtuin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(O)CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNC(CCC1=CN(CCOCCOCCOCCOCCNC([C@@H](NC(OCC2=CC=CC=C2)=O)CCCCNC(CCCCCCCCCCCCC)=S)=O)N=N1)=O)=O
Molecular Formula
C55H91N9O15S
Molecular Weight
1150.43
References & Citations
[1]Yu J, et al. Design, synthesis and biological evaluation of prostate-specific membrane antigen (PSMA) -targeted SIRT2 inhibitors. Bioorg Chem. 2024 Dec;153:107784.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6249049-01 0.1 mL
Immunoglobulin-Like Transcript 2 (LT2, Leukocyte Immunoglobulin-like Receptor Subfamily B Member 1, LIR-1, Leukocyte Immunoglobulin-like Receptor 1, CD85 Antigen-like Family Member J, ILT-2, Monocyte/Macrophage Immunoglobulin-like Receptor 7, MIR-7, CD85j
Ask
View Details 
MBS6249049-02 5x 0.1 mL
Immunoglobulin-Like Transcript 2 (LT2, Leukocyte Immunoglobulin-like Receptor Subfamily B Member 1, LIR-1, Leukocyte Immunoglobulin-like Receptor 1, CD85 Antigen-like Family Member J, ILT-2, Monocyte/Macrophage Immunoglobulin-like Receptor 7, MIR-7, CD85j
Ask
View Details 